Intrinsic Value of S&P & Nasdaq Contact Us

Forian Inc. FORA NASDAQ

NASDAQ Capital Marke • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
57/100
3/7 Pass
SharesGrow Intrinsic Value
$95.65
+4348.8%
Analyst Price Target
$4.50
+109.3%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Forian Inc. (FORA) has a negative trailing P/E of -23.3, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -4.30%.

Criteria proven by this page:

  • VALUE (91/100, Pass) — analyst target implies upside (+109.3%).
  • Trailing Earnings Yield -4.30% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings.
  • Analyst consensus target $4.50 (+109.3% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 57/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
57/100
SG Score
View full scorecard →
VALUE
91/100
Price-to-Earnings & upside
Proven by this page
FUTURE
100/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
35/100
→ Income
GROWTH
73/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — FORA

Valuation Multiples
P/E (TTM)-23.3
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio2.25
P/S Ratio2.22
EV/EBITDA-24.2
Per Share Data
EPS (TTM)$-0.09
Book Value / Share$0.96
Revenue / Share$0.97
FCF / Share$0.09
Yields & Fair Value
Earnings Yield-4.30%
Dividend Yield0.00%
SharesGrow IV$95.65 (+4348.8%)
Analyst Target$4.50 (+109.3%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2019 -529.9 0.00 -2,430.26 0.00 -
2020 -137.1 -0.47 60.62 1,253.47 -
2021 -10.8 -0.03 11.39 16.98 -
2022 -3.4 0.94 7.04 5.33 -
2023 8.4 -0.06 3.39 4.58 -
2024 -17.0 0.13 2.13 3.18 -
2025 -22.9 1.00 2.21 2.18 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2019 $-0.04 $0.00 $-1.29M -
2020 $-0.17 $544.87K $-4.98M -913.4%
2021 $-0.84 $16.88M $-26.55M -157.3%
2022 $-0.81 $28.01M $-25.97M -92.7%
2023 $0.36 $20.48M $11.11M 54.2%
2024 $-0.12 $20.15M $-3.77M -18.7%
2025 $-0.09 $30.26M $-2.87M -9.5%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $-0.04 $-0.04 – $-0.04 $32.17M $32.17M – $32.17M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message